Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.
about
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infectionsLinezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumoniaSafety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review.Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.Tigecycline pharmacokinetics, tolerability, safety, and effect on intestinal microflora in healthy Japanese male subjects.Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary DiseasePulmonary Delivery of Vancomycin Dry Powder Aerosol to Intubated RabbitsFrequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.Diet-Induced Obesity Does Not Alter Tigecycline Treatment Efficacy in Murine Lyme Disease.Assessment of linezolid prescriptions in three French hospitals.Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IV.In vitro susceptibility of Campylobacter jejuni from Kuwait to tigecycline & other antimicrobial agents.Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model.
P2860
Q26752922-A82BEC54-D91F-43AF-B192-977A156221F7Q28543159-CE0D6D80-286F-49A1-9446-42B706392D22Q34503844-2751E19C-F241-42AD-A176-18F92AF8ED07Q34922452-51E250F4-46EA-4FA4-9073-F944EBB917E7Q35045248-A4D28958-BBC1-44AA-A351-DE6197550067Q36887811-961875FC-BBF1-4FF7-B1E9-EA802438F6A9Q37091009-1C1849EF-16AA-4A60-B748-16FA0ADAB7F2Q37546815-FB8BF47E-6A93-4E15-B29A-425773E0274BQ37662663-A3320463-CA62-40D1-AB38-214A3F2FFB97Q40356411-6733C5F4-28A3-4023-8272-145373E71D6EQ40733777-80CABBB9-FDCE-470B-9198-16A7F17D4F43Q40824737-F6954C20-B19D-4769-B421-5250A7658AA1Q41589621-03558639-B632-42DE-828F-BCF24AC59788Q42103662-27BFC515-4632-4946-89F3-EDC6B299B7D9
P2860
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Comparison of the pharmacokine ...... d, tigecyclin, and daptomycin.
@ast
Comparison of the pharmacokine ...... d, tigecyclin, and daptomycin.
@en
type
label
Comparison of the pharmacokine ...... d, tigecyclin, and daptomycin.
@ast
Comparison of the pharmacokine ...... d, tigecyclin, and daptomycin.
@en
prefLabel
Comparison of the pharmacokine ...... d, tigecyclin, and daptomycin.
@ast
Comparison of the pharmacokine ...... d, tigecyclin, and daptomycin.
@en
P2860
P1476
Comparison of the pharmacokine ...... d, tigecyclin, and daptomycin.
@en
P2093
Hartmut Derendorf
P2860
P2888
P304
P356
10.1186/2047-783X-15-12-533
P407
P577
2010-11-01T00:00:00Z
P6179
1039402390